Clinical Trials Directory

Trials / Completed

CompletedNCT07003347

Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough

A Randomized, Double-Blind, Placebo Controlled Cross- Over Study to Investigate the Efficacy and Safety of SC0023, a Magnesium Salt Oral Spray Device, in Adults With Refractory or Unexplained Chronic Cough

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Kholood Altassan · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double-blind, placebo controlled cross-over study to investigate the efficacy and safety of SC0023 (an oral spray of magnesium based alkaline hypertonic divalent salt) in adults with refractory or unexplained chronic cough over 14 days. Approximately 20 participants being enrolled and randomized into the study.

Conditions

Interventions

TypeNameDescription
DEVICEoral spray of MgCl2Magnesium Salt Oral Spray Device
DEVICESalineoral saline aerosol

Timeline

Start date
2024-12-19
Primary completion
2025-07-30
Completion
2025-08-30
First posted
2025-06-04
Last updated
2026-01-21

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT07003347. Inclusion in this directory is not an endorsement.